LOUISVILLE, Ky. / Apr 13, 2023 / Business Wire / In support of its ongoing national commitment to improve housing stability for vulnerable members and communities, Humana Inc. (NYSE: HUM) today announced an additional $40 million investment to increase the supply of affordable housing. This latest round of funding raises Humana’s total financial commitment for affordable housing to $90 million and increases the scope of the program to include additional properties nationwide, including in the states of Arizona, Florida, Georgia, Illinois, Indiana, Kentucky, Louisiana, Michigan, Ohio, Oklahoma, South Carolina, Tennessee, Texas, Virginia, Washington and Wisconsin. At the same time, Humana continues to work with communities around the country to better understand the vital wrap-around services that help to stabilize and address health-related social needs.
“At Humana, we recognize that housing quality and related support services have a direct impact on health, which is why we are committed to increasing the supply of affordable housing and support services for vulnerable populations in the communities we serve,” said John Barger, President of Humana’s Medicaid business, Humana Healthy Horizons. “Through creative partnerships in affordable housing, we can help people gain access to safe and quality places to live and provide the stability they need to focus on achieving their best health. We are pleased to increase our investment in affordable housing to help revitalize properties in numerous communities across the country.”
Humana knows that housing stability is a key social determinant of health and is one of the issues the company is addressing through its social health initiatives. To help improve the health of its members and communities, Humana’s national housing strategy is focused on three key areas:
The company has initiatives underway to support all three areas, including its affordable housing commitment which now totals $90 million. This investment will help address the short supply of low-cost rental units and create affordable housing capacity in many of the communities that Humana serves.
“We truly value the partnership we’ve had with Humana over the years to help meet the growing demand for quality, affordable housing across the country,” said Steve Kropf, President and CEO of Raymond James Affordable Housing Investments. “We believe a stable, safe, and affordable home environment is essential to a high quality of life and leads to healthier communities. It’s through key partnerships like the one we have with Humana that we are able to significantly impact the health of residents across the country – together.”
About Raymond James Affordable Housing Investments
Raymond James Affordable Housing Investments is a wholly owned subsidiary of Raymond James Financial, Inc. (NYSE-RJF). Since 1972, subsidiaries of RJF have been among the leading syndicators of affordable housing. Raymond James Affordable Housing Investments has raised nearly $15 billion in equity for more than 2,500 properties across the United States since the inception of the tax credit program in 1986. For more information, visit raymondjames.com/ahi.
About Raymond James Financial, Inc.
Raymond James Financial, Inc., (NYSE: RJF) is a leading diversified financial services company providing private client group, capital markets, asset management, banking and other services to individuals, corporations and municipalities. The company has approximately 8,700 financial advisors. Total client assets are $1.17 trillion. Public since 1983, the firm is listed on the New York Stock Exchange under the symbol RJF. Additional information is available at raymondjames.com.
About Humana
Humana Inc. is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.
To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience with the goal of making health care easier to navigate and more effective.
More information regarding Humana is available to investors via the Investor Relations page of the company’s website at humana.com, including copies of:
Last Trade: | US$247.10 |
Daily Change: | 11.32 4.80 |
Daily Volume: | 3,889,989 |
Market Cap: | US$29.750B |
November 12, 2024 October 30, 2024 October 24, 2024 October 23, 2024 August 19, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB